We are live on ! Find out more
ADXN

Addex Therapeutics
ADXN

1 hedge funds and large institutions have $4.99K invested in Addex Therapeutics in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.09% less ownership

Funds ownership: 0.09% → 0% (-0.09%)

67% less funds holding

Funds holding: 3 → 1 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

99% less capital invested

Capital invested by funds: $717K → $4.99K (-$712K)

Holders
1
Holders Change
-2
Holders Change %
-66.67%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACM
ADAR1 Capital Management
Texas
+$3.84K

Top Sellers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
-$306K
2
AC
Armistice Capital
New York
-$260K
3
JSC
J. Stern & Co
United Kingdom
-$151K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
1
ADAR1 Capital Management
Texas
$4.99K +$3.84K +390 New
JSC
2
J. Stern & Co
United Kingdom
– -$151K -107,827 Closed
AC
3
Armistice Capital
New York
– -$260K -43,000 Closed
NMC
4
NEA Management Company
Maryland
– -$306K -9,000 Closed

ADXN Hedge Fund Activity: Q1 2024 in Review

1 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Addex Therapeutics (ADXN) for Q1 2024, worth a combined $4.99K — down 99% from $717K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of ADXN and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was ADAR1 Capital Management, opening a new position worth an estimated $3.84K. The largest seller was NEA Management Company, exiting entirely with an estimated $306K sold.

  • 1 institutional investor held Addex Therapeutics (ADXN) as of Q1 2024, down from 3 in Q4 2023.
  • Funds reported $4.99K of Addex Therapeutics stock for Q1 2024, down 99% quarter-over-quarter.
  • 1 fund opened new Addex Therapeutics positions in Q1 2024 and 3 closed out, a net change of -2 holders.
  • The largest Addex Therapeutics buyer in Q1 2024 was ADAR1 Capital Management, an estimated $3.84K added.
  • The largest Addex Therapeutics seller in Q1 2024 was NEA Management Company, an estimated $306K sold.

Based on aggregated 13F filings for Q1 2024.